The discovery of de novo gain-of-function mutations in NLRC4, which lead to infantile enterocolitis in patients, established a direct connection between VEO-IBD pathogenesis and dysregulated inflammasome activation [11, 38, 58, 60]. The gene discussed is NLRC4; the disease is inflammatory bowel disease.